Obinutuzumab in Combination With Ibrutinib in Treating Patients With Relapsed Mantle Cell Lymphoma
Clinical trial NCT02736617 · COMPLETED
Trial details
- NCT number
- NCT02736617
- Sponsor
- OHSU Knight Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-05
- Primary completion
- 2021-06-02
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.